3,4-dihydroisoquinolin-2(1H)-yl compounds
3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS Abstract )n OH The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | COATES, David Andrew REINHARD, Matthew Robert BEADLE, Christopher David SCHAUS, John Mehnert WOLFANGEL, Craig Daniel HAO, Junliang KRUSHINSKI JR., Joseph Herman |
| description | 3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS Abstract )n OH The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2016238934BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2016238934BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2016238934BB23</originalsourceid><addsrcrecordid>eNrjZNA01jHRTcnMqEwpys8szi8szczLz8nM0zXSMPTQ1K3MUUjOzy3IL81LKeZhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfGOoUYGhmZGxhaWxiZOTkbGRCoDAH71KRY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>3,4-dihydroisoquinolin-2(1H)-yl compounds</title><source>esp@cenet</source><creator>COATES, David Andrew ; REINHARD, Matthew Robert ; BEADLE, Christopher David ; SCHAUS, John Mehnert ; WOLFANGEL, Craig Daniel ; HAO, Junliang ; KRUSHINSKI JR., Joseph Herman</creator><creatorcontrib>COATES, David Andrew ; REINHARD, Matthew Robert ; BEADLE, Christopher David ; SCHAUS, John Mehnert ; WOLFANGEL, Craig Daniel ; HAO, Junliang ; KRUSHINSKI JR., Joseph Herman</creatorcontrib><description>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS Abstract )n OH The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170803&DB=EPODOC&CC=AU&NR=2016238934B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170803&DB=EPODOC&CC=AU&NR=2016238934B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COATES, David Andrew</creatorcontrib><creatorcontrib>REINHARD, Matthew Robert</creatorcontrib><creatorcontrib>BEADLE, Christopher David</creatorcontrib><creatorcontrib>SCHAUS, John Mehnert</creatorcontrib><creatorcontrib>WOLFANGEL, Craig Daniel</creatorcontrib><creatorcontrib>HAO, Junliang</creatorcontrib><creatorcontrib>KRUSHINSKI JR., Joseph Herman</creatorcontrib><title>3,4-dihydroisoquinolin-2(1H)-yl compounds</title><description>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS Abstract )n OH The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNA01jHRTcnMqEwpys8szi8szczLz8nM0zXSMPTQ1K3MUUjOzy3IL81LKeZhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfGOoUYGhmZGxhaWxiZOTkbGRCoDAH71KRY</recordid><startdate>20170803</startdate><enddate>20170803</enddate><creator>COATES, David Andrew</creator><creator>REINHARD, Matthew Robert</creator><creator>BEADLE, Christopher David</creator><creator>SCHAUS, John Mehnert</creator><creator>WOLFANGEL, Craig Daniel</creator><creator>HAO, Junliang</creator><creator>KRUSHINSKI JR., Joseph Herman</creator><scope>EVB</scope></search><sort><creationdate>20170803</creationdate><title>3,4-dihydroisoquinolin-2(1H)-yl compounds</title><author>COATES, David Andrew ; REINHARD, Matthew Robert ; BEADLE, Christopher David ; SCHAUS, John Mehnert ; WOLFANGEL, Craig Daniel ; HAO, Junliang ; KRUSHINSKI JR., Joseph Herman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2016238934BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>COATES, David Andrew</creatorcontrib><creatorcontrib>REINHARD, Matthew Robert</creatorcontrib><creatorcontrib>BEADLE, Christopher David</creatorcontrib><creatorcontrib>SCHAUS, John Mehnert</creatorcontrib><creatorcontrib>WOLFANGEL, Craig Daniel</creatorcontrib><creatorcontrib>HAO, Junliang</creatorcontrib><creatorcontrib>KRUSHINSKI JR., Joseph Herman</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COATES, David Andrew</au><au>REINHARD, Matthew Robert</au><au>BEADLE, Christopher David</au><au>SCHAUS, John Mehnert</au><au>WOLFANGEL, Craig Daniel</au><au>HAO, Junliang</au><au>KRUSHINSKI JR., Joseph Herman</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>3,4-dihydroisoquinolin-2(1H)-yl compounds</title><date>2017-08-03</date><risdate>2017</risdate><abstract>3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS Abstract )n OH The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2016238934BB2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 3,4-dihydroisoquinolin-2(1H)-yl compounds |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T12%3A22%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COATES,%20David%20Andrew&rft.date=2017-08-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2016238934BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |